$101.52 $2.59 (2.6%)

04:00 PM EDT on 08/16/19

Guardant Health Inc (NASDAQ:GH)

CAPS Rating: 5 out of 5

Current Price $101.52 Mkt Cap $8.3B
Open $100.40 P/E Ratio 0.00
Prev. Close $98.93 Div. (Yield) $0.00 (0.0%)
Daily Range $99.64 - $101.88 Volume 1,102,024
52-Wk Range $33.70 - $112.22 Avg. Daily Vol. 21

Caps

How do you think NASDAQ:GH will perform against the market?

Add Stock to CAPS Watchlist

All Players

204 Outperform
1 Underperform
 

All-Star Players

76 Outperform
0 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top NASDAQ:GH Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFEBCapital (87.37)
Submitted April 22, 2019

Q4 revenue of $32.9 million, up 64%, and FY2018 rev. of $90.6 million, up 82% YoY hints at multibillion opportunity associated with disrupting tissue biopsy genetic discovery. Growing use of liquid biopsy test in solid tumor cancer = FY 2019 revenue… More

MaestroFool (84.70)
Submitted March 20, 2019

High-flyer! Long-term, Guardant Health is doing fascinating things in oncology and there is a tremendous addressable market for their diagnostic offerings, but the story is nearing the top of a hype cycle and with the April 2 lockup expiration… More

NASDAQ:GH VS S&P 500 (SPY)

NASDAQ:GH Summary

Fools bullish on NASDAQ:GH are also bullish on:

Fools bearish on NASDAQ:GH are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about GH.

Recs

0
Member Avatar AnxiousBorrower (74.26) Submitted: 8/7/2019 12:27:09 AM : Outperform Start Price: $105.01 NASDAQ:GH Score: -4.85

Eventually will be acquired at a much higher price.

Recs

0
Member Avatar CarlUman (54.26) Submitted: 6/27/2019 9:48:26 AM : Outperform Start Price: $82.76 NASDAQ:GH Score: +23.66

A company that is leading change in the vast medical field. With change being adopted slower than innovation in this sector getting in now seems like a safe way to beat the market long term.

Recs

0
Member Avatar MarkFitzFool (42.05) Submitted: 5/13/2019 1:56:46 PM : Outperform Start Price: $71.30 NASDAQ:GH Score: +39.63

Pioneer and leader in liquid biopsies for cancer. Huge sales growth and massive addressable market. This is a huge part of the future of oncology. The holy grail is a liquid (blood) biopsy that can detect cancer so early that it can be eradicated before it becomes life-threatening. We're not there yet, but we will be in the future. I think GH can help lead the way. They provide liquid biopsies for early detection, detection of cancer recurrence, and for treatment selection. This is a company that is already, and will continue to be, a part of the future standard of care in oncology. We'll beat cancer, it's just a matter of time, and companies with technologies like this will be part of the solution.

Leaderboard

Find the members with the highest scoring picks in GH.

Score Leader

jmaleki333

jmaleki333 (< 20) Score: +220.47

The Score Leader is the player with the highest score across all their picks in GH.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
jmaleki333 < 20 10/11/2018 Outperform 5Y $31.26 +224.76% +4.29% +220.47 0 Comment
drum1234 58.57 12/24/2018 Outperform 5Y $33.51 +202.95% +20.80% +182.16 0 Comment
bulwnkl 82.95 12/24/2018 Outperform 5Y $33.51 +202.95% +20.80% +182.16 0 Comment
clickme999 87.41 1/4/2019 Outperform 5Y $34.82 +191.56% +16.62% +174.93 0 Comment
oceanbluela 70.80 1/4/2019 Outperform 5Y $34.82 +191.56% +16.62% +174.93 0 Comment
lcod 49.07 12/3/2018 Outperform 5Y $36.70 +176.62% +3.02% +173.60 0 Comment
baller89 83.20 11/30/2018 Outperform 5Y $36.78 +176.02% +5.20% +170.82 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Wakanda 99.84 11/21/2018 Outperform 5Y $36.60 +177.38% +8.19% +169.18 0 Comment
Darthtaco 82.20 1/4/2019 Outperform 5Y $35.97 +182.24% +14.62% +167.62 0 Comment
TMFProcess 81.78 12/20/2018 Outperform 5Y $35.84 +183.26% +16.32% +166.94 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBofASec 91.77 4/10/2019 Outperform NS $69.00 +47.13% +0.34% +46.79 0 Comment